Rationale and Design of a Randomized Clinical Trial Comparing Stress Reduction Treatment to Usual Cardiac Care: The Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) Trial
Authors:
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 72 (2) , 172-177
Abstract
Objective: To present the design of a multicenter, randomized trial testing the effects of stress reduction treatment (SRT) on the prevalence of shock-treated ventricular arrhythmias among patients with an implantable cardioverter defibrillator (ICD). Significant adjustment problems secondary to ICD shock can increase the likelihood of arrhythmias requiring shock for termination. Whether SRT can reduce arrhythmias requiring shock for termination in patients with ICDs has not been tested in clinical trials. Methods: New ICD recipients and previous recipients who have received an appropriate therapeutic shock in the last 6 months (n = 304) will be enrolled and randomized to either SRT or usual cardiac care. Participants complete a psychosocial questionnaire and undergo laboratory mental stress testing and 24-hour Holter monitoring with diary at study entry and approximately 4 months later. Follow-ups are completed at 6, 12, and 24 months post randomization to assess occurrence of ICD shock for ventricular arrhythmias (primary outcome), antitachycardia pacing events, medication changes, hospitalizations, deaths, and quality of life. Results: Log-rank test and Cox proportional hazards model will be used to test the effects of SRT on time to first shock-treated ventricular arrhythmia, with exploratory analyses testing the effects on overall frequency of ventricular arrhythmia. Secondary analyses will test the effects of SRT on laboratory stress-induced and 24-hour arrhythmogenic electrophysiological indices from pre to post treatment, and both quality of life and measures of anger across the 2 years of the study. Conclusions: The Reducing Vulnerability to ICD Shock-Treated Ventricular Arrhythmias (RISTA) Trial is the first large-scale, randomized, clinical trial designed to evaluate the effect of SRT on the prevalence of shock-treated arrhythmias among patients with an ICD. Results may demonstrate a treatment that can reduce vulnerability to arrhythmia-provoked shock and improve quality of life. RISTA = Reducing Vulnerability to ICD Shock-Treated Ventricular Arrhythmias; ICD = implantable cardioverter defibrillator; SRT = stress reduction treatment; UC = usual care; ATP = antitachycardia pacing; ECG = electrocardiogram; CAD = coronary artery disease; AVID = antiarrhythmics versus implantable defibrillators; MADIT = Multicenter Automatic Defibrillator Implantation Trial; SCD-HeFT = Sudden Cardiac Death-Heart Failure Trial; ANOVA = analysis of variance.Keywords
This publication has 48 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Quality of Life with Defibrillator Therapy or Amiodarone in Heart FailureNew England Journal of Medicine, 2008
- A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac DeathJACC, 2008
- Prophylactic Catheter Ablation for the Prevention of Defibrillator TherapyNew England Journal of Medicine, 2007
- Prevention of implantable defibrillator shocks by cognitive behavioral therapy: A pilot trialAmerican Heart Journal, 2006
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: Summary results of the recurrent coronary prevention projectAmerican Heart Journal, 1986
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The CES-D ScaleApplied Psychological Measurement, 1977